Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Wedbush Remains Bullish on Voyager Therapeutics (VYGR) Following 4Q Financials
March 18, 2016 8:29 AM EDTWedbush reiterated an Outperform rating and $36.00 price target on Voyager Therapeutics (NASDAQ: VYGR) following 4Q financial results.
Analyst David Nierengarten commented, "VYGR reported net income of ($8.8M), below our estimate of ($6.1M) in part due to GAAP expenses of $1.5M related to pre-IPO... More
Voyager Therapeutics (VYGR) Misses Q4 EPS by 12c
March 17, 2016 8:25 AM EDTVoyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.67), $0.12 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $4.94 million versus the consensus estimate of $3.73 million.
Cash, cash equivalents and marketable securities as of December 31, 2015 were approximately $224 million, compared to $161 million on September... More
